牛唐
11-18 21:18
今日美股评论（2024.11.15）
1、
$英伟达(NVDA)$
爆出利空，是否有配资机会？
2、
$因塞特医疗(INCY)$
、
$Madrigal Pharmaceuticals, Inc.(MDGL)$
、
$Tarsus Pharmaceuticals, Inc.(TARS)$
收购传闻再起，是否有配置机会？
3、
$Ascendis Pharma A/S(ASND)$
财报利空，是否有抄底机会？
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":372436445712528,"tweetId":"372436445712528","gmtCreate":1731935899793,"gmtModify":1731935902499,"author":{"id":3452938437060827,"idStr":"3452938437060827","authorId":3452938437060827,"authorIdStr":"3452938437060827","name":"牛唐","avatar":"https://static.tigerbbs.com/de2e2f2e2676bc8463b050f4e3ff17d2","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"社区优质创作者：发表过3篇及以上精华帖，且30天内发表过至少一篇精华帖并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.03","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"}}],"fanSize":6272,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body>今日美股评论（2024.11.15）\n<br>\n1、 <a href=\"https://laohu8.com/S/NVDA\">$英伟达(NVDA)$</a> 爆出利空，是否有配资机会？\n<br>\n2、 <a href=\"https://laohu8.com/S/INCY\">$因塞特医疗(INCY)$</a> 、 <a href=\"https://laohu8.com/S/MDGL\">$Madrigal Pharmaceuticals, Inc.(MDGL)$</a> 、 <a href=\"https://laohu8.com/S/TARS\">$Tarsus Pharmaceuticals, Inc.(TARS)$</a> 收购传闻再起，是否有配置机会？\n<br>\n3、 <a href=\"https://laohu8.com/S/ASND\">$Ascendis Pharma A/S(ASND)$</a> 财报利空，是否有抄底机会？</body></html>","htmlText":"<html><head></head><body>今日美股评论（2024.11.15）\n<br>\n1、 <a href=\"https://laohu8.com/S/NVDA\">$英伟达(NVDA)$</a> 爆出利空，是否有配资机会？\n<br>\n2、 <a href=\"https://laohu8.com/S/INCY\">$因塞特医疗(INCY)$</a> 、 <a href=\"https://laohu8.com/S/MDGL\">$Madrigal Pharmaceuticals, Inc.(MDGL)$</a> 、 <a href=\"https://laohu8.com/S/TARS\">$Tarsus Pharmaceuticals, Inc.(TARS)$</a> 收购传闻再起，是否有配置机会？\n<br>\n3、 <a href=\"https://laohu8.com/S/ASND\">$Ascendis Pharma A/S(ASND)$</a> 财报利空，是否有抄底机会？</body></html>","text":"今日美股评论（2024.11.15） 1、 $英伟达(NVDA)$ 爆出利空，是否有配资机会？ 2、 $因塞特医疗(INCY)$ 、 $Madrigal Pharmaceuticals, Inc.(MDGL)$ 、 $Tarsus Pharmaceuticals, Inc.(TARS)$ 收购传闻再起，是否有配置机会？ 3、 $Ascendis Pharma A/S(ASND)$ 财报利空，是否有抄底机会？","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/372436445712528","repostId":0,"isVote":1,"tweetType":1,"viewCount":227,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NVDA","INCY","ASND","TARS","MDGL"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":235,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/372436445712528"}
精彩评论